Page 168 - TD-3-4

Tumor Discovery CK2 deregulation in non-small-cell lung cancer

39. Liu Y, Amin EB, Mayo MW, et al. CK2α’ drives lung 41. Cesaro L, Zuliani AM, Travain VB, Salvi M. Exploring
cancer metastasis by targeting BRMS1 nuclear export and protein kinase CK substrate recognition and the dynamic
2
degradation. Cancer Res. 2016;76(9):2675-2686. response of substrate phosphorylation to kinase modulation.
doi: 10.1158/0008-5472.CAN-15-2888 Kinases Phosphatases. 2023;1(4):251-264.
40. Xie ZC, Tang RX, Gao X, et al. A meta-analysis and doi: 10.3390/kinasesphosphatases1040015
bioinformatics exploration of the diagnostic value and
molecular mechanism of mir-193a-5p in lung cancer. Oncol 42. Tsherniak A, Vazquez F, Montgomery PG, et al. Defining a
Lett. 2018;16(4):4114-4128. cancer dependency map. Cell. 2017;170(3):564-576.e16.
doi: 10.3892/ol.2018.9174 doi: 10.1016/j.cell.2017.06.010

Volume 3 Issue 4 (2024) 14 doi: 10.36922/td.4571